南美洲血脑屏障技术市场预测至 2028 年 - COVID-19 影响和技术区域分析（双特异性抗体 RMT 方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术）和应用（阿尔茨海默氏症™）病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等）
市场介绍
南美洲地区包括巴西、阿根廷和 SAM 的其他地区。预计巴西将占据该地区的主要市场份额。巴西是世界上面积和人口第五大国，正在经历全球最快的人口老龄化，老龄化人口会出现与年龄相关的神经退行性疾病，这可能会增加该国对肺装置的需求。在巴西，在区域和历史社会经济不平等的背景下，人口老龄化速度很快。根据在巴西进行的研究，妇女群体估计占绝大多数，老年人口数量为 1,690 万（56%），而老年人估计约有 1,690 万（56%）。 1330 万（44%）。神经退行性疾病的流行与巴西人口老龄化有关。巴西地理与统计研究所（IBGE）预计，到2060年，65岁以上人口将占总人口的25.5%。血脑屏障技术市场正受到脑癌患病率增加等因素的影响。例如，根据 Globocan 2020 报告，脑癌是巴西最常见的死亡原因。 2020年，巴西新增脑癌病例12260例，因脑癌和中枢神经系统癌症死亡10920例。这可能需要巴西的血脑屏障技术。同样，巴西所有年龄段脑癌的 5 年患病率约为每 10 万人中 15.17 例。在巴西，缺血性中风是常见的神经血管疾病类型，占2016年总死亡人数的61.8%。该数据由一项题为“2016年巴西中风负担：对全球脑卒中负担的分析”的研究发表。疾病研究结果报告还指出，70岁及以上人群的比例更高。然而，该国中风死亡率已经降低。该国的发展和进步使人们更容易获得教育和技术。此外，初级卫生保健的进步集中在中风和其他神经系统疾病的预防上。
南美洲多个发展中国家的存在使该地区成为关键的地区之一血脑屏障技术市场未来增长的市场。人口的增长、可支配收入的增加、对日常健康诊断的认识不断提高以及神经系统疾病患病率的上升是预计推动该地区血脑屏障技术治疗增长和需求的一些关键因素。然而，巴西、秘鲁、智利、厄瓜多尔和阿根廷等南美洲主要国家因COVID-19确诊病例和死亡人数较多，预计将影响这些国家的市场需求。头痛、发烧、嗅觉丧失、味觉丧失以及脑炎、吉兰-巴利综合征和缺血性中风都与严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染有关。 SARS-CoV-2 是当前冠状病毒病 (COVID-19) 大流行的罪魁祸首，它可以通过多种途径进入并影响中枢神经系统 (CNS)，包括轴突逆行运输或与血脑屏障的相互作用(BBB) 或血脑脊液 (CSF) 屏障。研究观察到 SARS-CoV-2 复制率较低，并伴有非常温和的炎症反应。所有这些因素预计将在未来几个季度对该地区血脑屏障技术市场的增长产生积极影响。
市场概况和动态
u>
南美洲的血脑屏障技术市场预计将从 2021 年的 6402 万美元增长到 2028 年的 2.9718 亿美元。预计 2021 年至 2028 年复合年增长率为 24.5%。纳米医学是一个快速发展的领域，其纳米颗粒或纳米结构用于医疗应用，特别是在向大脑输送药物的欠发达领域。人们对多功能纳米粒子（NP）穿越血脑屏障的能力寄予厚望。纳米技术的最新进展使得原本在大脑中分布不佳的药物能够被包装成具有大脑靶向特性的纳米颗粒。这些靶向载体系统通过将药物捕获或封装在颗粒中，并在其表面带有靶向肽/配体，从而实现 BBB 靶向，从而增强药物的递送。这些载体系统利用跨细胞途径（例如受体介导的内吞作用）穿过血脑屏障。固体脂质纳米颗粒的一个显着优点是它们的高脂溶性可以物理稳定纳米颗粒，从而增加药物的承载能力并导致药物的受控释放速率。尽管基于脂质的纳米颗粒和制剂由于渗透和滞留增加而具有延长的体循环时间和增加的肿瘤滞留，但它们最重要的限制因素是通过网状内皮系统从血流中快速清除。一些研究小组正在努力通过安装带有配体的纳米颗粒来改善对大脑的靶向性，这些配体是 BBB 摄取转运蛋白的底物，有助于转运到大脑。随着这项技术的进步，该系统可以有效地输送多种具有良好毒性的治疗药物。因此，使用纳米颗粒进行脑部药物输送预计将成为预测期内的趋势。
关键细分市场
在技术方面，增加渗透性细分市场在2021年南美血脑屏障技术市场中占据最大份额。从应用来看，2021年，帕金森病细分市场占据南美洲血脑屏障技术市场的最大份额。
主要来源和上市公司
准备本血脑屏障技术报告时参考的一些主要一手和二手来源南美市场包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有梯瓦制药工业有限公司（Teva Pharmaceutical Industries Ltd.）； F.霍夫曼-拉罗氏有限公司；礼来公司；百时美施贵宝公司；辉瑞公司；和强生公司Johnson Services, Inc. 等。
购买报告的理由
- 了解南美血脑屏障技术市场格局并确定最有可能保证丰厚回报
- 了解南美血脑屏障技术市场不断变化的竞争格局，保持领先地位
- 通过识别最有可能销售前景的细分市场，有效规划南美血脑屏障技术市场的并购和合作交易
- 帮助通过敏锐的洞察力和洞察力做出明智的业务决策综合分析南美血脑屏障技术市场各个细分市场的市场表现
- 获取南美地区2021-2028年各个细分市场的市场收入预测 .
南美洲血脑屏障技术市场细分
南美洲血脑屏障技术市场 –按技术
- 双特异性抗体RMT方法
- 特洛伊木马方法
- 增加渗透性
- 被动扩散
- 其他非侵入性 BBB 技术
南美洲血脑屏障技术市场 -通过应用
- 阿尔茨海默病
- 癫痫
- 帕金森病
- 多发性硬化症
- 猎人综合症
- 脑癌
- 其他 >
南美血脑屏障技术市场 -按国家/地区
- 巴西
- 阿根廷
- SAM 的其余部分
南美血脑屏障技术市场 –提及的公司
- 梯瓦制药工业有限公司 ;
- F.霍夫曼罗氏有限公司 ;
- 礼来公司和公司 ; ; ;
- 百时美施贵宝公司 ;
- 辉瑞公司 ; ;
- 强生公司约翰逊服务公司 ;
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Blood Brain Barrier Technologies Market – By Technology
1.3.2 South America Blood Brain Barrier Technologies Market – By Application
1.3.3 South America Blood Brain Barrier Technologies Market– By Country
2. South America Blood Brain Barrier Technologies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South America Blood Brain Barrier Technologies Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. South America Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Boosting Prevalence of Neurological Disorders
5.1.2 Accelerating Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.2 Market Restraints
5.2.1 Barriers in Brain Medication Delivery
5.3 Market Opportunities
5.3.1 Elevating Number of Product Approvals and Launches
5.4 Future Trends
5.4.1 Surging Demand Nanoparticles for Brain Drug Delivery
5.5 Impact Analysis
6. South America Blood Brain Barrier Technologies – Market Analysis
6.1 South America Blood Brain Barrier Technologies Market Revenue Forecast and Analysis
7. South America Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Overview
7.2 South America Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
7.3 Bispecific Antibody RMT Approach
7.3.1 Overview
7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Trojan Horse Approach
7.4.1 Overview
7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Increasing Permeability
7.5.1 Overview
7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Passive Diffusion
7.6.1 Overview
7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Other Non-Invasive BBB Technologies
7.7.1 Overview
7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8. South America Blood Brain Barrier Technologies Market Analysis – By Application
8.1 Overview
8.2 South America Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parkinson’s Disease
8.5.1 Overview
8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
8.6.1 Overview
8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hunter’s Syndrome
8.7.1 Overview
8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Brain Cancer
8.8.1 Overview
8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
9. South America Blood Brain Barrier Technologies Market – Country Analysis
9.1 Overview
9.1.1 South America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
9.1.1.1 Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Brazil: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.1.3 Brazil: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.2 Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Argentina: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.2.3 Argentina: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.3 Rest of South America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 Rest of South America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 Rest of South America: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.3.3 Rest of South America: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on South America Blood Brain Barrier Technologies Market
10.1 Impact Assessment of COVID-19 Pandemic
11. South America Blood Brain Barrier Technologies Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eli Lilly and Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson and Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South America Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. Brazil: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Argentina: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. Rest of South America: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. Rest of South America: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Organic Developments Done By Companies
Table 9. Inorganic Developments Done By Companies
Table 10. Glossary of Terms, Blood Brain Barrier Technologies Market
LIST OF FIGURES
Figure 1. South America Blood Brain Barrier Technologies Market Segmentation
Figure 2. South America Blood Brain Barrier Technologies Market Segmentation, By Country
Figure 3. South America Blood Brain Barrier Technologies Market Overview
Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market
Figure 5. Brazil to Show Significant Growth during the Forecast Period
Figure 6. South America Blood Brain Barrier Technologies Market, Industry Landscape
Figure 7. South America (SAM) PEST Analysis
Figure 8. South America Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. South America Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
Figure 10. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. South America Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
Figure 16. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. South America: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. South America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
Figure 25. Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Rest of South America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Impact Of COVID-19 Pandemic in South America Country Markets- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America blood brain barrier technologies market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution